Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.

@article{PrietoAlhambra2011FractureRB,
  title={Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.},
  author={Daniel Prieto-Alhambra and Muhammad Kassim Javaid and Andrew Judge and Joe Maskell and Amit Kiran and Frank de Vries and Cyrus Cooper and Nigel K. Arden},
  journal={Arthritis and rheumatism},
  year={2011},
  volume={63 4},
  pages={
          992-1001
        }
}
OBJECTIVE The association between osteoarthritis (OA) and fractures remains unclear. OA patients have increased bone mass, but no corresponding decrease in fracture rate. This study was undertaken to determine the fracture rates in patients with hip OA undergoing a total hip replacement (THR), as compared with disease-free controls, and to assess the association between bisphosphonate use and postsurgery fracture risk. METHODS We conducted a population-based parallel-cohorts study. All… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS

Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry

  • Clinical orthopaedics and related research
  • 2015
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 43 REFERENCES

Multiple imputation of missing values

VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

Temporal trends in hip and knee replacement in the United Kingdom: 1991 to 2006.

  • The Journal of bone and joint surgery. British volume
  • 2010
VIEW 1 EXCERPT